These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31434314)

  • 1. Circulating miRNAs as Potential Biomarkers Associated with Cardiac Remodeling and Fibrosis in Chagas Disease Cardiomyopathy.
    Nonaka CKV; Macêdo CT; Cavalcante BRR; Alcântara AC; Silva DN; Bezerra MDR; Caria ACI; Tavora FRF; Neto JDS; Noya-Rabelo MM; Rogatto SR; Ribeiro Dos Santos R; Souza BSF; Soares MBP
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31434314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs miR-1, miR-133a, miR-133b, miR-208a and miR-208b are dysregulated in Chronic Chagas disease Cardiomyopathy.
    Ferreira LR; Frade AF; Santos RH; Teixeira PC; Baron MA; Navarro IC; Benvenuti LA; Fiorelli AI; Bocchi EA; Stolf NA; Chevillard C; Kalil J; Cunha-Neto E
    Int J Cardiol; 2014 Aug; 175(3):409-17. PubMed ID: 24910366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy.
    Roncarati R; Viviani Anselmi C; Losi MA; Papa L; Cavarretta E; Da Costa Martins P; Contaldi C; Saccani Jotti G; Franzone A; Galastri L; Latronico MV; Imbriaco M; Esposito G; De Windt L; Betocchi S; Condorelli G
    J Am Coll Cardiol; 2014 Mar; 63(9):920-7. PubMed ID: 24161319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic miR-21 Silencing Reduces Cardiac Fibrosis and Modulates Inflammatory Response in Chronic Chagas Disease.
    Nonaka CKV; Sampaio GL; Silva KN; Khouri R; Macedo CT; Chagas Translational Research Consortium ; Rogatto SR; Ribeiro Dos Santos R; Souza BSF; Soares MBP
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33804922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unraveling the role of miRNAs as biomarkers in Chagas cardiomyopathy: Insights into molecular pathophysiology.
    Ribeiro HG; Galdino OA; de Souza KSC; Rosa Neta AP; Lin-Wang HT; Cunha-Neto E; Rezende AA; Silbiger VN
    PLoS Negl Trop Dis; 2024 Feb; 18(2):e0011865. PubMed ID: 38300899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating MicroRNAs and myocardial involvement severity in chronic Chagas cardiomyopathy.
    Gómez-Ochoa SA; Bautista-Niño PK; Rojas LZ; Hunziker L; Muka T; Echeverría LE
    Front Cell Infect Microbiol; 2022; 12():922189. PubMed ID: 36004323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Fang L; Ellims AH; Moore XL; White DA; Taylor AJ; Chin-Dusting J; Dart AM
    J Transl Med; 2015 Sep; 13():314. PubMed ID: 26404540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation and mitochondria in the pathogenesis of chronic Chagas disease cardiomyopathy.
    Nunes JPS; Roda VMP; Andrieux P; Kalil J; Chevillard C; Cunha-Neto E
    Exp Biol Med (Maywood); 2023 Nov; 248(22):2062-2071. PubMed ID: 38235691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNAs may play a major role in the control of gene expression in key pathobiological processes in Chagas disease cardiomyopathy.
    Laugier L; Ferreira LRP; Ferreira FM; Cabantous S; Frade AF; Nunes JP; Ribeiro RA; Brochet P; Teixeira PC; Santos RHB; Bocchi EA; Bacal F; Cândido DDS; Maso VE; Nakaya HI; Kalil J; Cunha-Neto E; Chevillard C
    PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008889. PubMed ID: 33351798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of circulating miRNAs as biomarkers of chronic Chagas heart disease via a small RNA-Seq approach.
    Villar SR; Herreros-Cabello A; Callejas-Hernández F; Maza MC; Del Moral-Salmoral J; Gómez-Montes M; Rodríguez-Angulo HO; Carrillo I; Górgolas M; Bosch-Nicolau P; Molina I; Pérez-Molina JA; Monge-Maillo B; Bottasso OA; Beloscar J; Pérez AR; Fresno M; Gironès N
    Sci Rep; 2024 Jan; 14(1):1187. PubMed ID: 38216639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chagas disease cardiomyopathy: immunopathology and genetics.
    Cunha-Neto E; Chevillard C
    Mediators Inflamm; 2014; 2014():683230. PubMed ID: 25210230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel miRNA Screen Identifies miRNA-4454 as a Candidate Biomarker for Ventricular Fibrosis in Patients with Hypertrophic Cardiomyopathy.
    Thottakara T; Lund N; Krämer E; Kirchhof P; Carrier L; Patten M
    Biomolecules; 2021 Nov; 11(11):. PubMed ID: 34827715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with benznidazole and pentoxifylline regulates microRNA transcriptomic profile in a murine model of Chagas chronic cardiomyopathy.
    Silva Grijó Farani P; Iandra da Silva Ferreira B; Begum K; Vilar-Pereira G; Pereira IR; Fernández-Figueroa EA; Cardenas-Ovando RA; Almeida IC; Roy S; Lannes-Vieira J; Moreira OC
    PLoS Negl Trop Dis; 2023 Mar; 17(3):e0011223. PubMed ID: 36972298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomal microRNAs miR-30d-5p and miR-126a-5p Are Associated with Heart Failure with Preserved Ejection Fraction in STZ-Induced Type 1 Diabetic Rats.
    Huang JP; Chang CC; Kuo CY; Huang KJ; Sokal EM; Chen KH; Hung LM
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of cardiomyopathy associated circulating miRNA biomarkers in patients with muscular dystrophy using a complementary cardiovascular magnetic resonance and plasma profiling approach.
    Becker S; Florian A; Patrascu A; Rösch S; Waltenberger J; Sechtem U; Schwab M; Schaeffeler E; Yilmaz A
    J Cardiovasc Magn Reson; 2016 May; 18(1):25. PubMed ID: 27150296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-3113-5p, miR-223-3p, miR-133a-3p, and miR-499a-5p are sensitive biomarkers to diagnose sudden cardiac death.
    Yan F; Chen Y; Ye X; Zhang F; Wang S; Zhang L; Luo X
    Diagn Pathol; 2021 Jul; 16(1):67. PubMed ID: 34332589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
    Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
    BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-1-3p that correlates with left ventricular function of HCM can serve as a potential target and differentiate HCM from DCM.
    Li M; Chen X; Chen L; Chen K; Zhou J; Song J
    J Transl Med; 2018 Jun; 16(1):161. PubMed ID: 29885652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectin-3 (Gal-3) and the tissue inhibitor of matrix metalloproteinase (TIMP-2) as potential biomarkers for the clinical evolution of chronic Chagas cardiomyopathy.
    Menezes CADS; de Oliveira ALG; Barbosa ICM; de Jesus ACP; Chaves AT; Rocha MODC
    Acta Trop; 2024 Apr; 252():107153. PubMed ID: 38373528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker.
    Vilming Elgaaen B; Olstad OK; Haug KB; Brusletto B; Sandvik L; Staff AC; Gautvik KM; Davidson B
    BMC Cancer; 2014 Feb; 14():80. PubMed ID: 24512620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.